Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 824 M880 M890 M867 M825 M814 M 3.4 B Research & development —————— — Operating income 235 M858 M305 M704 M731 M705 M 2.44 B Non-Operating Income, Total 484 M527 M493 M477 M557 M515 M 2.04 B Interest expense, net of interest capitalized -46 M-32 M-44 M-44 M-29 M-31 M -148 M Non-Operating Income, excl. Interest Expenses 530 M559 M537 M521 M586 M546 M 2.19 B Unusual income/expense —————— — Pretax income 248 M815 M269 M555 M736 M683 M 2.24 B Equity in earnings —————— — Taxes 39 M135 M14 M108 M83 M124 M 329 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 210 M680 M255 M446 M653 M559 M 1.91 B Discontinued operations —————— — Net income 210 M680 M255 M446 M653 M559 M 1.91 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 208 M672 M252 M441 M645 M552 M 1.89 B Basic earnings per share (Basic EPS) 4.916.16.0910.7116.2114.22 47.23 Diluted earnings per share (Diluted EPS) 4.916.16.0910.7116.2114.22 47.23 Average basic shares outstanding 42.3 M41.8 M41.4 M41.6 M39.8 M38.8 M — Diluted shares outstanding 42.3 M41.8 M41.4 M41.6 M39.8 M38.8 M — EBITDA 262 M853 M290 M576 M765 M719 M 2.35 B EBIT 308 M885 M334 M620 M794 M750 M 2.5 B Cost of revenue 2.89 B2.47 B2.84 B2.66 B2.22 B2.17 B 9.88 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) -46 M-32 M-44 M-44 M-29 M-31 M -148 M